Singer Capital Markets is delighted to have been appointed as Nominated Adviser to Oncimmune Holdings plc with immediate effect.
Singer Capital Markets will now be acting as Nominated Adviser and Joint Broker to the Company, having been appointed as Joint Broker in August 2020.
About Oncimmune Holdings plc
Oncimmune is a leading immunodiagnostics developer, primarily focused on the growing fields of immuno-oncology, autoimmune disease and infectious diseases. Oncimmune has a diversified and growing revenue base, both from its portfolio of diagnostic products to detect early-stage cancer and its contract discovery and development service business whose platform delivers actionable insights into therapies to the Company’s pharmaceutical and biotech partners.
Ticker: ONC
Market Cap: £134.79 million*
Website: Click here
*As at 02/11/2021
